Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Compassionate Use Individual Request Program for GSK2857916 in Multiple Myeloma

Trial Profile

Compassionate Use Individual Request Program for GSK2857916 in Multiple Myeloma

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 12 Dec 2018

At a glance

  • Drugs GSK 2857916 (Primary)
  • Indications Multiple myeloma
  • Focus Expanded access; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 12 Dec 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top